Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › VA › Fredericksburg › NPI 1376876664
Clinic

Spotsylvania Medical Center INC

Spotsylvania Medical Center INC was paid $31.02M by Medicaid between Jan 2018 and Dec 2024, across 227 billing codes. Its largest line is 99283, emergency room visit (moderate) — 30% of everything it billed.

33Billing provider infoSPOTSYLVANIA MEDICAL CENTER INC
FREDERICKSBURG, VA 22408
33aNPI1376876664assigned 09/17/2009
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$31.02M
24GClaims726,364
24DCodes billed227
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Ambulatory Surgical Clinic/Center providers in Virginia

Rank by total paid#1 of 55
Median peer was paid$123K
This provider vs. median252×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201876,558$2.06M
2019108,753$3.41M
202090,585$3.53M
2021101,680$4.10M
2022106,761$4.84M
2023131,833$6.68M
2024incomplete110,194$6.40M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 30% 49,260 43,178 $9.32M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 21% 36,815 31,156 $6.46M
99282 Emergency department visit for the evaluation and management, low to moderate severity 6.3% 10,615 9,681 $1.95M
74177 Computed tomography, abdomen and pelvis; with contrast material 4.8% 6,848 6,134 $1.49M
70450 Computed tomography, head or brain; without contrast material 4.2% 6,373 5,718 $1.29M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.8% 6,718 5,834 $1.17M
G0378 Hospital observation service, per hour 2.7% 6,259 3,540 $829K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.3% 3,371 2,992 $707K
71275 Computed tomographic angiography, chest, with contrast material 2.1% 2,361 2,144 $661K
96361 Intravenous infusion, hydration; each additional hour 2.1% 2,843 2,491 $644K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 2.0% 1,044 994 $605K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.9% 3,238 3,003 $593K
215 more codes
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.3% 8,112 $401K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.2% 1,002 $357K
G0383 Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 1,530 $257K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 5,064 $231K
76830 Ultrasound, transvaginal <1% 2,273 $221K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 2,022 $217K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,446 $216K
76818 <1% 2,502 $216K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,658 $177K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 282 $175K
59025 Fetal non-stress test <1% 910 $175K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 3,620 $161K
80053 Comprehensive metabolic panel <1% 39,567 $160K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 884 $141K
93971 <1% 1,455 $135K
76801 <1% 2,245 $118K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 1,028 $111K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 4,779 $106K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 913 $102K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 1,385 $86K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 540 $79K
72125 Computed tomography, cervical spine; without contrast material <1% 1,591 $73K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,755 $72K
97162 <1% 448 $72K
71046 Radiologic examination, chest; 2 views <1% 12,781 $70K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 24,962 $59K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,987 $55K
97164 <1% 243 $54K
70551 Magnetic resonance imaging, brain; without contrast material <1% 225 $53K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 3,151 $52K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 54 $46K
80048 Basic metabolic panel (calcium, ionized) <1% 8,686 $39K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 20,957 $38K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 3,632 $35K
85027 <1% 50,124 $34K
71045 Radiologic examination, chest; single view <1% 12,387 $32K
87040 <1% 4,206 $32K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,743 $31K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,002 $30K
83880 <1% 3,996 $26K
84484 <1% 14,996 $25K
96375 Therapeutic injection; each additional sequential IV push <1% 12,265 $22K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 6,616 $21K
71250 <1% 305 $20K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 263 $20K
12001 <1% 88 $17K
85379 <1% 3,638 $16K
97163 <1% 85 $15K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 415 $15K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 93 $14K
76642 <1% 90 $14K
70496 <1% 40 $14K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,573 $13K
72131 <1% 154 $12K
74018 <1% 1,541 $12K
J7030 Infusion, normal saline solution , 1000 cc <1% 19,060 $11K
73030 <1% 1,496 $11K
97535 Self-care/home management training, each 15 minutes <1% 343 $10K
73564 <1% 1,767 $9K
83605 <1% 4,304 $9K
93970 <1% 82 $9K
72110 <1% 642 $8K
76770 <1% 84 $8K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 138 $8K
81001 <1% 19,420 $8K
84443 Thyroid stimulating hormone (TSH) <1% 4,450 $7K
70486 <1% 84 $7K
97116 <1% 311 $7K
97032 <1% 133 $7K
73630 <1% 2,019 $7K
73610 <1% 1,902 $7K
83690 <1% 14,214 $6K
73130 <1% 1,670 $6K
80076 <1% 1,364 $6K
10060 <1% 33 $6K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 28 $6K
84702 <1% 4,820 $5K
76536 <1% 37 $5K
72100 <1% 519 $5K
83735 <1% 6,200 $5K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,440 $4K
84703 <1% 9,721 $4K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 16,141 $4K
86850 <1% 2,202 $4K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 13,226 $4K
73110 <1% 770 $4K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 14 $3K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 139 $3K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 11,394 $3K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,949 $3K
85610 <1% 6,421 $3K
70491 <1% 16 $3K
80061 Lipid panel <1% 1,117 $3K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 13,894 $3K
97161 <1% 29 $3K
80051 <1% 1,650 $3K
83036 Hemoglobin; glycosylated (A1C) <1% 1,106 $3K
86900 <1% 3,271 $3K
J1170 Injection, hydromorphone, up to 4 mg <1% 3,790 $3K
96376 <1% 2,370 $2K
87070 <1% 4,839 $2K
82565 <1% 1,891 $2K
J7120 Ringers lactate infusion, up to 1000 cc <1% 5,376 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 10,327 $2K
81025 <1% 6,882 $2K
90715 <1% 77 $2K
73502 <1% 277 $2K
90714 <1% 78 $2K
70498 <1% 37 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 11,428 $2K
86901 <1% 3,270 $1K
94729 <1% 43 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 998 $1K
71271 <1% 13 $1K
77066 Tomosynthesis, mammo <1% 67 $1K
82947 <1% 1,638 $1K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,480 $1K
81003 <1% 9,510 $1K
36415 Collection of venous blood by venipuncture <1% 719 $1K
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,635 $1K
84145 <1% 62 $1K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,281 $980.55
94060 <1% 30 $967.61
87210 <1% 1,184 $930.06
87807 <1% 3,887 $927.47
J3010 Injection, fentanyl citrate, 0.1 mg <1% 4,332 $826.29
85730 <1% 2,939 $790.58
84520 <1% 1,649 $772.04
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 5,429 $707.30
73590 <1% 209 $685.70
J2270 Injection, morphine sulfate, up to 10 mg <1% 6,290 $623.79
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 4,639 $530.35
94726 <1% 15 $511.87
82550 <1% 679 $474.15
J2060 Injection, lorazepam, 2 mg <1% 1,725 $362.43
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,185 $351.90
86140 <1% 361 $301.20
94621 <1% 13 $292.50
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 3,699 $274.45
87186 <1% 1,556 $256.04
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 2,224 $254.34
87077 <1% 1,558 $249.74
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 808 $247.47
87081 <1% 1,482 $243.14
84439 <1% 58 $181.76
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 24 $142.29
J7050 Infusion, normal saline solution, 250 cc <1% 1,595 $140.02
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 1,570 $119.93
J2550 Injection, promethazine hcl, up to 50 mg <1% 1,100 $118.61
J1815 Injection, insulin, per 5 units <1% 1,575 $111.18
73080 <1% 56 $108.79
73060 <1% 15 $95.27
73090 <1% 107 $95.27
84100 <1% 362 $87.12
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,054 $75.08
J1644 Injection, heparin sodium, per 1000 units <1% 1,211 $74.65
72040 <1% 12 $67.41
73560 <1% 45 $67.40
84550 <1% 66 $44.79
85652 <1% 35 $44.34
84112 <1% 14 $42.03
82728 <1% 13 $37.17
J3475 Injection, magnesium sulfate, per 500 mg <1% 645 $31.89
88304 <1% 57 $29.07
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg <1% 764 $27.50
87147 <1% 83 $22.74
82803 <1% 406 $20.96
83550 <1% 14 $18.57
87205 <1% 104 $18.35
82272 <1% 18 $16.59
83540 <1% 14 $16.59
82570 <1% 12 $12.88
80047 <1% 176 $11.03
J0780 Injection, prochlorperazine, up to 10 mg <1% 282 $5.88
85384 <1% 15 $5.26
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 376 $5.03
J0360 Injection, hydralazine hcl, up to 20 mg <1% 90 $3.60
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram <1% 302 $3.50
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 13 $1.20
J1630 Injection, haloperidol, up to 5 mg <1% 15 $0.96
99152 0% 27 $0.00
82010 0% 17 $0.00
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program 0% 200 $0.00
S4991 Nicotine patches, non-legend 0% 104 $0.00
S0028 Injection, famotidine, 20 mg 0% 311 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 101 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 50 $0.00
73140 0% 60 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 115 $0.00
J7510 Prednisolone oral, per 5 mg 0% 174 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 137 $0.00
88312 0% 59 $0.00
82248 0% 16 $0.00
A9270 Non-covered item or service 0% 3,599 $0.00
86308 0% 54 $0.00
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 0% 325 $0.00
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 0% 728 $0.00
82150 0% 380 $0.00
J3490 Unclassified drugs 0% 763 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 435 $0.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 0% 224 $0.00
87088 0% 16 $0.00
J2704 Injection, propofol, 10 mg 0% 158 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 85 $0.00
J0500 Injection, dicyclomine hcl, up to 20 mg 0% 20 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 18 $0.00
C1769 Guide wire 0% 65 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 14 $0.00
36000 0% 12 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 67 $0.00
99153 Mod sedat endo service >5yrs 0% 14 $0.00
J3480 Injection, potassium chloride, per 2 meq 0% 13 $0.00
J8540 Dexamethasone, oral, 0.25 mg 0% 14 $0.00
71101 0% 24 $0.00
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialFALADE, SARAH (CFO)
Same official

Other billing entities under FALADE, SARAH

Full network →
ProviderLocationPaid
Spotsylvania Medical Center INC.Fredericksburg, VA$52K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.